Login

Reggie Groves, CEO, REVA Medical Inc 00:00:00

Share On Facebook Share On Twitter

Reva develops bioresorbable coronary scaffolds for the treatment of cardiovascular disease.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exchange Europe 2023: Carlos Hernandez, Senior Tax Manager | David DeStefano, CEO, Vertex IncVERX:NMQ
00:10:00
Inside All for One Steeb. Interview mit Serkar | Lars Landwehrkamp, CEO, All for One Group SEA1OSX:GER
00:10:00
Uncovering Offshore Funds: Insights on Tax Reform and Transparency - Ricardo Martner, Commissioner at ICRICT
00:10:00
Phunware Inc (NASDAQ) COO Randall announces Hareesh Achi as the new CEO of Toggle3D.ai, transitioning from Evan Gappelberg..|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
Inca Mineral's Exciting Discoveries in the Northern Territory: Hitting IOCG-Style Alteration and Sulfide Minerals in All Drilled Holes | Gareth Lloyd , BSc (HONS) NON – EXECUTIVE DIRECTOR at Inca Minerals Ltd
00:10:00
Expensive Equities: Insights from Columbia Threadneedle Investments
00:10:00
Supriya Lifescience Limited Earnings Review & Business Outlook by Director Saloni Wagh | Saloni Wagh, Director, Supriya Lifescience Limited.
00:10:00
Group 6 Metals Aims for First Tungsten Concentrate Production Early Next Year | Keith McKnight, CEO , Group 6 Metals Ltd.
00:10:00
The Future of Work: Insights from ASGN CEO Ted Hanson | Theodore Hanson - CEO of ASGN Incorporated
00:10:00
Bessemer supports founders and CEOs from their early days through every stage of growth|Ariel Sterman,Vice President,Bessemer Venture Partners
00:10:00
A Discussion on Decentralization and Renewable Technologies | Louis Maurice, CEO, Groupe Okwind SA.
00:10:00
Balancing Marketing and Tactical Business Development for Financial Advisors

© 2026 Nehu